News Industry News CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial June 01, 2020
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015